Changing the Prognosis of Metastatic Cervix Uteri Adenosquamous Carcinoma through a Multimodal Approach: A Case Report

被引:8
作者
Georgescu, Mihai Teodor [1 ]
Georgescu, Dragos Eugen [2 ]
Georgescu, Teodor Florin [2 ]
Serbanescu, Luiza Georgia [1 ]
机构
[1] Carol Davila Univ Med & Pharm, Dept Radiol Oncol Hematol 8, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Dept Gen Surg 10, Ion Movila St 5-7, RO-030167 Bucharest, Romania
关键词
Adenocarcinoma; Cervical cancer; Radiation therapy; Chemotherapy; Surgery; SQUAMOUS-CELL CARCINOMA; ADENOCARCINOMA; CANCER; CA-125;
D O I
10.1159/000511564
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adenocarcinoma and adenosquamous carcinoma (AS) are 2 rare histological types of cervix uteri cancer constituting almost 20% of all cervix cancers, leading to a lack in patient management guidelines. We report the case of a 32-year-old woman with an oligometastatic cervix AS for which a multimodal treatment approach was used. Despite the patient's bad prognosis, a complete response was achieved, which further resulted in excellent local control and prolonged survival. This case report serves the purpose of encouraging multidisciplinary team work and out-of-the-box thinking that should result in an individualized treatment for rare cancer subtypes. (c) 2020 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:1545 / 1551
页数:7
相关论文
共 27 条
[1]   Prognostic factors in adenocarcinoma of the uterine cervix [J].
Baalbergen, A ;
Ewing-Graham, PC ;
Hop, WCJ ;
Struijk, P ;
Helmerhorst, TJM .
GYNECOLOGIC ONCOLOGY, 2004, 92 (01) :262-267
[2]   Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer [J].
Bao, Zhirong ;
Wang, Dajiang ;
Chen, Shupeng ;
Chen, Min ;
Jiang, Dazhen ;
Yang, Chunxu ;
Liu, Hui ;
Dai, Jing ;
Xie, Conghua .
RADIATION ONCOLOGY, 2019, 14 (01)
[3]  
BEREK JS, 1985, OBSTET GYNECOL, V65, P46
[4]   TUMOR-ANTIGENS CA-19.9, CA-125, AND CEA IN CARCINOMA OF THE UTERINE CERVIX [J].
BORRAS, G ;
MOLINA, R ;
XERCAVINS, J ;
BALLESTA, A ;
IGLESIAS, J .
GYNECOLOGIC ONCOLOGY, 1995, 57 (02) :205-211
[5]   Incidence trends of adenocarcinoma of the cervix in 13 European countries [J].
Bray, F ;
Carstensen, B ;
Moller, H ;
Zappa, M ;
Zakelj, MP ;
Lawrence, G ;
Hakama, M ;
Weiderpass, E .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (09) :2191-2199
[6]   Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach [J].
Cheng, Jen-Yu ;
Huang, Eng-Yen ;
Hsu, Shun-Neng ;
Wang, Chong-Jong .
BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1068)
[7]   COMPARISON OF THE PATTERN OF METASTATIC SPREAD OF SQUAMOUS-CELL CANCER AND ADENOCARCINOMA OF THE UTERINE CERVIX [J].
DRESCHER, CW ;
HOPKINS, MP ;
ROBERTS, JA .
GYNECOLOGIC ONCOLOGY, 1989, 33 (03) :340-343
[8]  
DUK JM, 1989, OBSTET GYNECOL, V73, P661
[9]   ADENOCARCINOMA AS AN INDEPENDENT RISK FACTOR FOR DISEASE RECURRENCE IN PATIENTS WITH STAGE IB CERVICAL-CARCINOMA [J].
EIFEL, PJ ;
BURKE, TW ;
MORRIS, M ;
SMITH, TL .
GYNECOLOGIC ONCOLOGY, 1995, 59 (01) :38-44
[10]   Adenocarcinoma of the Uterine Cervix: Why Is it Different? [J].
Fujiwara, Keiichi ;
Monk, Bradley ;
Devouassoux-Shisheboran, Mojgan .
CURRENT ONCOLOGY REPORTS, 2014, 16 (12)